Cargando…

Risk and mitigation actions for clinical trials during COVID-19 pandemic (RiMiCOPa)

The COVID-19 virus diffusion is, nowadays, global and any clinical trial is potentially affected by the direct and indirect consequences of the COVID-19 during the pandemic. Any step, from protocol design to result's disclosure, needs to be revised to assess the impact of the COVID-19 on the st...

Descripción completa

Detalles Bibliográficos
Autores principales: Bacchieri, Antonella, Rossi, Andrea, Morelli, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703225/
https://www.ncbi.nlm.nih.gov/pubmed/33283069
http://dx.doi.org/10.1016/j.conctc.2020.100682